Summary

Article Metadata

Nanoparticles Target Cancer, Cardiovascular Disease

This is a news story, published by Yahoo, that relates primarily to Trojan news.

Trojan news

For more Trojan news, you can click here:

more Trojan news

disease research news

For more disease research news, you can click here:

more disease research news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about

cardiovascular nanodrug

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer drugs news, cardiovascular drug efficacy news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

cancer nanodrugs

The Conversation

The Conversation

•

Could a single drug treat the two leading causes of death in the US: cancer and cardiovascular disease?

The Conversation

Summary

Nutrition label

80% Informative

Nanotubes a very small particle made of carbon that is over 10,000 times thinner than a human hair can go into specific immune cells, travel through the bloodstream and enter tumors as a Trojan horse.

Nanotube -loaded nanotubes can be loaded that stimulates immune cells that stimulate immune cells and thus reduce plaque debris.

These nanoparticles can also be used to improve diagnosis of cardiovascular disease.

Nanoparticle-based cancer drugs first entered the clinic in 1995 , and researchers have developed many others since.

But there is currently only one cardiovascular nanodrug approved by the Food and Drug Administration .

This suggests opportunity for new nanotherapy approaches to improve cardiovascular drug efficacy and reduce side effects.

VR Score

76

Informative language

74

Neutral language

21

Article tone

informal

Language

English

Language complexity

68

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

43

https://doi.org/10.1038/s41569-021-00594-5 https://www.khanacademy.org/science/biology/macromolecules/lipids/a/lipids https://www.khanacademy.org/science/ap-biology/chemistry-of-life/properties-structure-and-function-of-biological-macromolecules/a/carbohydrates https://doi.org/10.4049/jimmunol.0902583 https://doi.org/10.1016/j.jconrel.2012.03.020 https://doi.org/10.1161/CIRCULATIONAHA.120.051451 https://doi.org/10.1038/s41565-019-0619-3 https://theconversation.com/profiles/bryan-smith-1438426?utm_source=Yahoo&utm_medium=related-link&utm_campaign=byline-link&utm_content=article-205461 https://www.nhlbi.nih.gov/health/atherosclerosis https://doi.org/10.1161/CIRCULATIONAHA.115.020406 https://theconversation.com/nanoparticles-are-the-future-of-medicine-researchers-are-experimenting-with-new-ways-to-design-tiny-particle-treatments-for-cancer-180009 https://doi.org/10.1161/hc0902.104353 https://doi.org/10.1161/CIRCRESAHA.114.302721 https://doi.org/10.1161/CIR.0000000000000678 https://theconversation.com/institutions/michigan-state-university-1349?utm_source=Yahoo&utm_medium=related-link&utm_campaign=byline-link&utm_content=article-205461 https://theconversation.com/every-cancer-is-unique-why-different-cancers-require-different-treatments-and-how-evolution-drives-drug-resistance-199249 https://doi.org/10.1038/nature01322 https://doi.org/10.1016%2Fj.bpj.2018.07.038 https://doi.org/10.1073/pnas.1511698112 https://doi.org/10.1016/j.ccell.2016.10.006 https://doi.org/10.1038/s44161-023-00232-y https://doi.org/10.1021/acsnano.0c00245 https://doi.org/10.1002/adfm.202101005 https://doi.org/10.1592/phco.28.5.570 https://doi.org/10.1172/jci81603 http://theconversation.com/nanoparticles-are-the-future-of-medicine-researchers-are-experimenting-with-new-ways-to-design-tiny-particle-treatments-for-cancer-180009?utm_source=Yahoo&utm_medium=related-link&utm_campaign=related-link1&utm_content=article-205461 https://doi.org/10.1021/acsnano.8b08875 https://doi.org/10.1016/s0168-3659(99)00248-5 https://doi.org/10.1016/j.biomaterials.2016.05.018 https://doi.org/10.1056/NEJMc2029834 http://theconversation.com/us?utm_source=Yahoo&utm_medium=related-link&utm_campaign=related-link-0&utm_content=article-205461 https://doi.org/10.1038%2Fnnano.2014.62 https://doi.org/10.3389/fphar.2021.731798 https://doi.org/10.1073/pnas.1322725111 https://doi.org/10.1038/nature18935 https://theconversation.com/repurposing-generic-drugs-can-reduce-time-and-cost-to-develop-new-treatments-but-low-profitability-remains-a-barrier-174874 http://theconversation.com/cells-routinely-self-cannibalize-to-take-out-their-trash-aiding-in-survival-and-disease-prevention-199148?utm_source=Yahoo&utm_medium=related-link&utm_campaign=related-link0&utm_content=article-205461 http://theconversation.com/many-people-think-cannabis-smoke-is-harmless-a-physician-explains-how-that-belief-can-put-people-at-risk-211601?utm_source=Yahoo&utm_medium=related-link&utm_campaign=related-link2&utm_content=article-205461 https://doi.org/10.1016/j.immuni.2019.06.025 https://doi.org/10.1007/s12274-020-3111-3 https://doi.org/10.1016/j.cell.2009.05.045 https://theconversation.com/90-of-drugs-fail-clinical-trials-heres-one-way-researchers-can-select-better-drug-candidates-174152 https://scholar.google.com/citations?user=wD6KbXkAAAAJ&hl=en

Source diversity

5

doi.org www.khanacademy.org theconversation.com www.nhlbi.nih.gov scholar.google.com

Affiliate links

no affiliate links

Read full article